Sustained Release Agent

Abstract Purpose Conventional chemotherapy is limited by premature drug leakage, systemic toxicity, and inefficient intracellular co-delivery, leading to reduced therapeutic...

PRESS RELEASE Producing Pharmaceutical-Grade Lactose: Lactalis’ Energy Challenges and Environmental Commitments We organized an exclusive Q&A session with Maeva Croué — CSR Coordinator for Lactalis...

Abstract Carbohydrate-based polymers are increasingly recognized as sustainable materials for additive manufacturing. For the first time, Starch 1500®, a partially...

Abstract A gastro-retentive drug delivery system based on a tablet-integrated superporous hydrogel (SPH) was developed using Famotidine as a model...

Abstract Poloxamer-based hydrogels, composed of thermoreversible triblock copolymers, are promising drug delivery systems due to their ability to transition from...

Abstract Background: Rebamipide (REB) is a poorly water-soluble drug with limited ocular bioavailability, necessitating advanced delivery strategies for sustained therapy in...

Abstract This study addresses a critical challenge in delivering a drug to prevent angina in the early morning hours, aligning...

Abstract Objectives This study aims to investigate the effect of compaction pressure, coating polymer, pellet core, and spatial arrangement on...

Abstract Background/Objectives: Rebamipide is a gastroprotective agent with poor aqueous solubility and rapid gastrointestinal clearance, leading to reduced therapeutic efficiency. This...

CELLETS® Pharmaceutical Starter Cores for Pellets & Functional Coatings CELLETS® are high-purity pharmaceutical starter cores. They combine spherical geometry with...